- Home
- GRRR vs SRDX Comparison
GRRR vs SRDX Comparison
Compare GRRR & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRRR
- SRDX
- Stock Information
- Founded
- GRRR 2001
- SRDX 1979
- Country
- GRRR United Kingdom
- SRDX United States
- Employees
- GRRR N/A
- SRDX N/A
- Industry
- GRRR Computer Software: Prepackaged Software
- SRDX Medical/Dental Instruments
- Sector
- GRRR Technology
- SRDX Health Care
- Exchange
- GRRR Nasdaq
- SRDX Nasdaq
- Market Cap
- GRRR 391.9M
- SRDX 457.0M
- IPO Year
- GRRR N/A
- SRDX 1998
- Fundamental
- Price
- GRRR $20.07
- SRDX $31.91
- Analyst Decision
- GRRR Buy
- SRDX Buy
- Analyst Count
- GRRR 1
- SRDX 3
- Target Price
- GRRR $18.00
- SRDX $43.00
- AVG Volume (30 Days)
- GRRR 1.3M
- SRDX 230.7K
- Earning Date
- GRRR 08-14-2025
- SRDX 11-05-2025
- Dividend Yield
- GRRR N/A
- SRDX N/A
- EPS Growth
- GRRR N/A
- SRDX N/A
- EPS
- GRRR N/A
- SRDX N/A
- Revenue
- GRRR $93,325,178.00
- SRDX $120,801,000.00
- Revenue This Year
- GRRR $38.13
- SRDX N/A
- Revenue Next Year
- GRRR $28.55
- SRDX $3.38
- P/E Ratio
- GRRR N/A
- SRDX N/A
- Revenue Growth
- GRRR 18.22
- SRDX N/A
- 52 Week Low
- GRRR $3.33
- SRDX $26.00
- 52 Week High
- GRRR $44.15
- SRDX $40.39
- Technical
- Relative Strength Index (RSI)
- GRRR 66.31
- SRDX 36.39
- Support Level
- GRRR $17.22
- SRDX $31.20
- Resistance Level
- GRRR $18.30
- SRDX $32.50
- Average True Range (ATR)
- GRRR 0.95
- SRDX 0.87
- MACD
- GRRR 0.26
- SRDX -0.26
- Stochastic Oscillator
- GRRR 75.35
- SRDX 19.92
About GRRR Gorilla Technology Group Inc.
Gorilla Technology Group Inc is engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.
About SRDX Surmodics Inc.
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.